Study Experience: Pancreatic Cancer

Historical clinical trial data (HCTD) is reshaping how sponsors design, validate, and accelerate clinical development. Medidata's regulatory-grade HCTD enables organizations to benchmark outcomes, refine eligibility criteria, optimize study populations, and evaluate innovative trial designs with greater confidence.

This fact sheet highlights how Medidata has partnered with sponsors to build synthetic control arms, support regulatory engagement, address recruitment challenges, and generate evidence that informed investment and development decisions. From pancreatic cancer and glioblastoma to lung cancer and CAR-T programs, these collaborations demonstrate how Medidata's HCTD can reduce uncertainty, improve trial efficiency, and create more patient-centric pathways to approval. Discover how access to robust historical datasets is helping sponsors make smarter decisions earlier and increase the likelihood of clinical and regulatory success.